Skip to main content
. 2020 Jan 15;5(1):92–101. doi: 10.1016/j.bioactmat.2020.01.006

Fig. 5.

Fig. 5

Tumor volume of CT-26 carcinoma following treatment of saline, AH1 peptide vaccine, AH1 + unconjugated P60 FoxP3-inhibiting peptide, AH1 + unconjugated P60 + unconjugated CD28Apt, or AH1 + conjugated CD28Apt-P60 show prevention of tumors upon vaccination of AH1 + CD28-Apt-P60. Injections were given at a dose of 125 pmol every 2 days for 10 days before tumor inoculation. Adapted and reprinted with permission from ref. 148.